|
Acino Holding AG - Comparative Business Analysis Snapshot
Business Description
Acino Holding AG Formerly known as Schweizerhall Holding, Inc. The Group's principal activity is that of a Holding Company with interests in the chemical industry. The Group's activities specializes in the development, registration, approval, manufacturing and packaging of pharmaceuticals and generics in Europe and supplier of chemical raw materials, intermediates, specialty chemicals and customized mixtures on the Swiss market. The Group operates through two divisions. Peroral segment includes medications that are administered orally. Parenteral segment includes dosages that are not administered through gastrointestinal tract. The Group operates in Switzerland, Germany, United Kingdom, Ireland, France, Rest of Europe and Rest of World.
Competitor Analysis
This analysis compares Acino Holding AG with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
